The site compiles price increases for brand name drugs. Overall, 775 brand-name drugs increased in price in 2024, with an average hike of 4.5%.
Here are the reported price increases in 2023 and 2024 for the most commonly prescribed antidepressants:
- Sertraline (brand name Zoloft)
2024 increase: not reported
2023 increase: 7% - Escitalopram (brand name Lexapro)
2024 increase: 5%
2023 increase: 5% - Trazodone
2024 increase: not reported - Fluoxetine (brand name Prozac)
2024 decrease: -20.8%
2023 increase: 3% - Bupropion (brand name Wellbutrin XL 24-hour release)
2024 increase: 9.9%
2023 increase: 6.2% - Duloxetine (brand name Cymbalta)
2024 increase: not reported
2023 increase; 3% - Quetiapine (Seroquel)
2024 increase: not reported - Citalopram (Celexa)
2024 increase: not reported - Venlafaxine (brand name Effexor)
2024 increase: not reported
2023 increase: 7% - Aripiprazole (brand name Abilify Maintena for injection)
2024 increase: 3.7%
2023 increase: 6.5%
At the Becker's Fall Behavioral Health Summit, taking place November 4–5 in Chicago, behavioral health leaders and executives will explore strategies for expanding access to care, integrating services, addressing workforce challenges and leveraging innovation to improve outcomes across the behavioral health continuum. Apply for complimentary registration now.